biostudies-literatureUnknown28(5)Papalamprakopoulou ZThe present study was funded by the National Institute of Diabetes and Digestive and Kidney Diseases (award number: R01DK123205), a Patient-Centered Outcomes Research Institute (PCORI) Award (IHS-1507-31640), the Troup Fund of the Kaleida Health Foundation, and the University at Buffalo Accelerator award.<h4>Background</h4>Facilitated telemedicine is highly effective for hepatitis C virus (HCV) treatment among people with opioid use disorder (OUD). However, the long-term impact of sustained virological response (SVR) through this model of treatment remains unexplored. We examined how people with OUD perceive SVR achieved through facilitated telemedicine.<h4>Methods</h4>We conducted two focus group discussions (FGDs) with nine participants at least 5 years post-SVR through a randomised controlled trial of facilitated telemedicine in opioid treatment programmes (OTPs) (New York State, 2018-2020). Eligibility required active OTP enrolment at the time of FGDs. We used a semi-structured interview guide and performed thematic analysis of FGD transcripts.<h4>Results</h4>Participants had a mean agHealth expectations : an international journal of public participation in health care and health policye70404https://www.ebi.ac.uk/biostudies/studies/S-EPMC12457984biostudies-literatureLong-Term Benefits Following Hepatitis C Cure Through Facilitated Telemedicine; Experiences of People With Opioid use Disorder Five Years After Achieving a Sustained Virological Response.PMC12457984Papalamprakopoulou ZDang THUpdike PFGonzalez CJHernandez NWethington EShapiro MFDharia ATedesco CJTalal AHCorl CfalseLong-Term Benefits Following Hepatitis C Cure Through Facilitated Telemedicine; Experiences of People With Opioid use Disorder Five Years After Achieving a Sustained Virological Response.<h4>Background</h4>Facilitated telemedicine is highly effective for hepatitis C virus (HCV) treatment among people with opioid use disorder (OUD). However, the long-term impact of sustained virological response (SVR) through this model of treatment remains unexplored. We examined how people with OUD perceive SVR achieved through facilitated telemedicine.<h4>Methods</h4>We conducted two focus group discussions (FGDs) with nine participants at least 5 years post-SVR through a randomised controlled trial of facilitated telemedicine in opioid treatment programmes (OTPs) (New York State, 2018-2020). Eligibility required active OTP enrolment at the time of FGDs. We used a semi-structured interview guide and performed thematic analysis of FGD transcripts.<h4>Results</h4>Participants had a mean ag2025-01-01T00:00:00Z2025 Oct2026-06-03T19:52:32.643Z2026-05-01T03:10:34.173ZS-EPMC124579844099015210.1111/hex.70404